Chronic infusion of salusin-α and -β exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice

Atherosclerosis

Volumn 212, Issue 1, 2010, Pages 70-77

  Nagashima, Masaharu ^a   Watanabe, Takuya ^a   Shiraishi, Yuji ^a   Morita, Ryou ^a   Terasaki, Michishige ^a   Arita, Shigeko ^a   Hongo, Shigeki ^a   Sato, Kengo ^b   Shichiri, Masayoshi ^c   Miyazaki, Akira ^a   Hirano, Tsutomu ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Foam cell formation; Macrophage; Oxidized LDL; Salusins

Indexed keywords

APOLIPOPROTEIN E; CD36 ANTIGEN; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; OXIDIZED LOW DENSITY LIPOPROTEIN; PEPTIDE DERIVATIVE; PROTEIN ANTIBODY; SALUSIN ALPHA; SALUSIN ALPHA ANTIBODY; SALUSIN BETA; SALUSIN BETA ANTIBODY; SCAVENGER RECEPTOR A; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTINUOUS INFUSION; CONTROLLED STUDY; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; FOAM CELL; GENE EXPRESSION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SELF EVALUATION; TREATMENT DURATION;

ACETYL-COA C-ACETYLTRANSFERASE; ANIMALS; ANTIGENS, CD36; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL ESTERS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FOAM CELLS; GENE EXPRESSION REGULATION; HEART RATE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, SUBCUTANEOUS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, KNOCKOUT; SCAVENGER RECEPTORS, CLASS A; TIME FACTORS;

EID: 77956227663     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.04.027     Document Type: Article

References (15)

1. Pennings M., Meurs I., Ye D., et al. Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. FEBS Lett 2006, 580:5588-5596.
2. Miyazaki A., Sakashita N., Lee O., et al. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler Thromb Vasc Biol 1998, 18:1568-1574.
3. Shichiri M., Ishimaru S., Ota T., Nishikawa T., Isogai T., Hirata Y. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 2003, 9:1166-1172.
4. Suzuki N., Shichiri M., Akashi T., et al. Systemic distribution of salusin expression in the rat. Hypertens Res 2007, 30:1255-1262.
5. Sato K., Koyama T., Tateno T., Hirata Y., Shichiri M. Presence of immunoreactive salusin-α in human serum and urine. Peptides 2006, 27:2561-2566.
6. Sato K., Sato T., Susumu T., Koyama T., Shichiri M. Presence of immunoreactive salusin-β in human plasma and urine. Regul Pept 2009, 158:63-67.
7. Izumiyama H., Tanaka H., Egi K., Sunamori M., Hirata Y., Shichiri M. Synthetic salusins as cardiac depressors in rat. Hypertension 2005, 45:419-425.
8. Yu F., Zhao J., Yang J., et al. Salusins promote cardiomyocyte growth but does not affect cardiac function in rats. Regul Pept 2004, 122:191-197.
9. Hong-Xiao Y., Li L., Yan-Xia P., et al. Salusins protect neonatal rat cardiomyocytes from serum deprivation-induced cell death through upregulation of GRP78. J Cardiovasc Pharmacol 2006, 48:41-46.
10. Watanabe T., Nishio K., Kanome T., et al. Impact of salusin-α and -β on human macrophage foam cell formation and coronary atherosclerosis. Circulation 2008, 117:638-648.
11. Shiraishi Y., Watanabe T., Suguro T., et al. Chronic urotensin II administration enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice. J Hypertens 2008, 26:1955-1965.
12. 1 on macrophage foam cell formation and atherosclerosis. Circ Res 2009, 105:500-510.
13. Shichiri M. Reply to 'Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities'. Nat Med 2007, 13:661-662.
14. Watanabe T, Suguro T., Kanome T., et al. Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages. Hypertension 2005, 46:738-744.
15. Watanabe T., Suguro T., Sato K., et al. Serum salusin-α levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients. Hypertens Res 2008, 31:463-468.